[go: up one dir, main page]

WO2007011265A8 - Method for blocking noggin2 target specific activities - Google Patents

Method for blocking noggin2 target specific activities

Info

Publication number
WO2007011265A8
WO2007011265A8 PCT/RU2006/000382 RU2006000382W WO2007011265A8 WO 2007011265 A8 WO2007011265 A8 WO 2007011265A8 RU 2006000382 W RU2006000382 W RU 2006000382W WO 2007011265 A8 WO2007011265 A8 WO 2007011265A8
Authority
WO
WIPO (PCT)
Prior art keywords
noggin2
blocking
target specific
specific activities
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2006/000382
Other languages
French (fr)
Russian (ru)
Other versions
WO2007011265A1 (en
Inventor
Andrei Georgievich Zaraisky
Fedor Mikhailovich Eroshkin
Andrei Vyacheslavovic Bairamov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2007011265A1 publication Critical patent/WO2007011265A1/en
Publication of WO2007011265A8 publication Critical patent/WO2007011265A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to proteins, in particular to a noggin2 protein controlling a cell differentiation by inhibiting subfamily TGF-β proteins and to methods for the use thereof.
PCT/RU2006/000382 2005-07-21 2006-07-18 Method for blocking noggin2 target specific activities Ceased WO2007011265A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2005123287/13A RU2354662C2 (en) 2005-07-21 2005-07-21 Noggin2-based activin activity blocking method
RU2005123287 2005-07-21

Publications (2)

Publication Number Publication Date
WO2007011265A1 WO2007011265A1 (en) 2007-01-25
WO2007011265A8 true WO2007011265A8 (en) 2007-10-18

Family

ID=37669061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2006/000382 Ceased WO2007011265A1 (en) 2005-07-21 2006-07-18 Method for blocking noggin2 target specific activities

Country Status (2)

Country Link
RU (1) RU2354662C2 (en)
WO (1) WO2007011265A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2391352C1 (en) * 2008-10-24 2010-06-10 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН METHOD OF BLOCKING SIGNAL PATH ACTIVATED BY TGF-beta FACTOR OF VgI IN ANIMAL CELLS
RU2407799C1 (en) * 2009-06-18 2010-12-27 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН METHOD OF BLOCKING SINGALLING PATHWAY ACTIVATED BY TGF-beta FACTOR DERRIERE IN ANIMAL CELLS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US20070078101A1 (en) * 2003-01-21 2007-04-05 Brivanlou Ali H Regulation of tgf-beta signaling by tomoregulin

Also Published As

Publication number Publication date
RU2005123287A (en) 2007-01-27
RU2354662C2 (en) 2009-05-10
WO2007011265A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
AU2006272804A8 (en) Concentrated protein lyophilates, methods, and uses
GB0809236D0 (en) Valve, actuator and control system therefor
WO2008066630A3 (en) Methods for reprogramming adult somatic cells and uses thereof
AU2006268374A8 (en) Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation
ZA200801168B (en) Fusion proteins between plant cell-wall degrading enzymes, and their uses
EP1955177A4 (en) Methods, systems, and apparatus for multi-domain markers
WO2008094945A3 (en) Compounds and methods for modulating protein expression
WO2006070023A3 (en) Method for reversing multiple resistance in animal cells
WO2005108428A3 (en) Cd40 splice variants and their uses
WO2007087601A8 (en) Modulating plant protein levels
GB2414288B (en) Hydraulic control valve, system and methods
GB0506477D0 (en) Position detection system, game system, and control method for position detection system
WO2007019178A3 (en) Corn protein concentrates
WO2006034035A3 (en) Treatment of ischemia
EP1895683A4 (en) Communication control method, communication control system and control program thereof
WO2007056083A3 (en) Biosynthetic polypeptide fusion inhibitors
WO2005034840A3 (en) Identification of kinase inhibitors
WO2007062248A3 (en) Insecticidal compositions and uses thereof
WO2007033374A3 (en) Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
WO2007011265A8 (en) Method for blocking noggin2 target specific activities
WO2006047728A3 (en) Bmp gene and fusion protein
WO2007057393A3 (en) Aqueous rodenticide formulations
WO2005091754A3 (en) Novel cyclopentenedione antifungal compounds and methods for their use
WO2006015305A3 (en) Systems and methods for ion mobility control
HK1115817A (en) Concentrated protein lyophilates, methods, and uses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06784075

Country of ref document: EP

Kind code of ref document: A1